Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)

Study:

Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)

Rationale:

n/a

Purpose:

The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease during peri-approval/initial commercialization in relation to the outcomes of the Sapphire Clinical Trial. The devices to be utilized are the Cordis PRECISE Nitinol Stent Systems and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Carotid Artery Disease Device: -PRECISE Nitinol Stent System (5F, 5.5F and 6F)
Device: ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW)
Phase 3

Verified by Cordis Corporation July, 2007

Sponsored by: Cordis Corporation
Information provided by: Cordis Corporation
ClinicalTrials.gov identifier: NCT00231231

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study

Cleveland Clinic
Cleveland, Ohio 44195
United States

Sidney A. Cohen, MD, PhD., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site